GeneDx Holdings
53 hedge funds and large institutions have $50.8M invested in GeneDx Holdings in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 10 closing their positions.
889% more call options, than puts
Call options by funds: $1.5M | Put options by funds: $152K
13% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 15
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.82% less ownership
Funds ownership: 54.93% → 54.11% (-0.82%)
9% less funds holding
Funds holding: 58 → 53 (-5)
39% less capital invested
Capital invested by funds: $83.8M → $50.8M (-$33M)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$1.35M |
| 2 |
Charles Schwab
San Francisco,
California
|
-$567K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$338K |
| 4 |
BlackRock
New York
|
-$161K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$123K |
WGS Hedge Fund Activity: Q3 2023 in Review
53 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q3 2023, worth a combined $50.8M — down 39% from $83.8M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of WGS and 5 opened new positions — a net loss of 5 holders — while 15 trimmed existing stakes and 17 added.
The largest buyer was Oracle Investment Management, adding an estimated $705K. The largest seller was Millennium Management, exiting entirely with an estimated $1.35M sold.
- 53 institutional investors held GeneDx Holdings (WGS) as of Q3 2023, down from 58 in Q2 2023.
- Funds reported $50.8M of GeneDx Holdings stock for Q3 2023, down 39% quarter-over-quarter.
- 5 funds opened new GeneDx Holdings positions in Q3 2023 and 10 closed out, a net change of -5 holders.
- The largest GeneDx Holdings buyer in Q3 2023 was Oracle Investment Management, an estimated $705K added.
- The largest GeneDx Holdings seller in Q3 2023 was Millennium Management, an estimated $1.35M sold.
Based on aggregated 13F filings for Q3 2023.